SCHEMBL21988960

SCHEMBL21988960

CC(=O)c1cc2c(cnn2CC(=O)O)cc1-n1cccn1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMO O15229 6/20 0.44
EGFR P00533 1/20 0.36
KDM4E B2RXH2 2/20 0.35
LMNA P02545 2/20 0.35
KCNH2 Q12809 1/20 0.35
MEN1 O00255 1/20 0.35
ALDH1A1 P00352 1/20 0.35
GAA P10253 1/20 0.35
MAPT P10636 1/20 0.35
G6PD P11413 1/20 0.35
KMT2A Q03164 1/20 0.35
CYP4F2 P78329 1/20 0.34
CYP4A11 Q02928 1/20 0.34
HPGD P15428 1/20 0.33
HSD17B10 Q99714 1/20 0.33
HCRTR1 O43613 1/20 0.33
HCRTR2 O43614 1/20 0.33
CCKAR P32238 2/20 0.33
CCKBR P32239 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25806736 0.92 ALDH1A1 (0.36) KMOKDM4ELMNAKCNH2MEN1
SCHEMBL30046479 0.88 SYK (0.39) KDM4ELMNAKCNH2MEN1ALDH1A1
SCHEMBL22045489 0.88 SYK (0.39) KDM4ELMNAKCNH2MEN1ALDH1A1
SCHEMBL22044745 0.86 KCNH2 (0.35) KMOKDM4ELMNAKCNH2MEN1
SCHEMBL30045875 0.86 KCNH2 (0.35) KMOKDM4ELMNAKCNH2MEN1
SCHEMBL22044746 0.82 MEN1 (0.37) LMNAKCNH2MEN1ALDH1A1GAA
SCHEMBL21989062 0.82 KCNH2 (0.43) KMOEGFRKDM4ELMNAKCNH2
SCHEMBL21989064 0.82 KCNH2 (0.43) KMOEGFRKDM4ELMNAKCNH2
SCHEMBL22046557 0.81 KCNH2 (0.35) KDM4ELMNAKCNH2MEN1ALDH1A1
SCHEMBL21988835 0.80 KCNH2 (0.34) KDM4ELMNAKCNH2MEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230382892-A1 Chemical Compounds PFIZER INC. (US) 2023-11-30 US disclosed
US-11702405-B2 Chemical compounds PFIZER INC. (US) 2023-07-18 US disclosed
EP-3886984-A1 PYRAZOLES AS MODULATORS OF HEMOGLOBIN Pfizer Inc. (US) 2021-10-06 EP disclosed
US-11014908-B2 Chemical compounds PFIZER INC. (US) 2021-05-25 US disclosed
WO-2020109994-A1 PYRAZOLES AS MODULATORS OF HEMOGLOBIN PFIZER INC. (US) 2020-06-04 WO disclosed
US-20200172512-A1 Chemical Compounds PFIZER INC. (US) 2020-06-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200172512-A1 Chemical Compounds HBZ, HBB, HBS1L KMO 690/4885EGFR 4769/4885KDM4E 2745/4885
US-11702405-B2 Chemical compounds HBZ, HBB, HBS1L KMO 690/4885EGFR 4769/4885KDM4E 2745/4885
US-20230382892-A1 Chemical Compounds HBZ, HBB, HBS1L KMO 690/4885EGFR 4769/4885KDM4E 2745/4885
US-11014908-B2 Chemical compounds HBZ, HBB, HBS1L KMO 690/4885EGFR 4769/4885KDM4E 2745/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.